What Happened?
Menlo Park, -based Geron Promoted Stephen Rosenfield as Chief Legal Officer
Date of management change: January 31, 2019
Menlo Park, -based Geron Promoted Stephen Rosenfield as Chief Legal Officer
We are a biopharmaceutical company developing first-in-class therapies for cancer. Imetelstat, a novel, first-in-class telomerase inhibitor, is our product candidate in clinical development. Telomerase enables cancer cells to maintain telomere length, which provides them with the capacity for limitless cellular replication. Imetelstat is a potent and specific inhibitor of telomerase. Based on clinical data we obtained in late 2012, we may develop imetelstat to treat one or more hematologic myeloid malignancies such as myelofibrosis, or MF, myelodysplastic syndromes, or acute myelogenous leukemia.
Stephen Rosenfield is Chief Legal Officer at Geron. Previously, Stephen held various senior legal leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Dunn Brian, Allen Todd, Kimball Edward, Fang Michelle, Fato Luciana, Browdy Michelle, Bridges Summer, Gauthier Daniel, Rago Lori, Medford Kimberly, Wergeles Adam
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.